FI20000303A0 - Compounds Useful for the Treatment or Prevention of Alpha-2B Adrenoceptor Mediated Disease - Google Patents

Compounds Useful for the Treatment or Prevention of Alpha-2B Adrenoceptor Mediated Disease

Info

Publication number
FI20000303A0
FI20000303A0 FI20000303A FI20000303A FI20000303A0 FI 20000303 A0 FI20000303 A0 FI 20000303A0 FI 20000303 A FI20000303 A FI 20000303A FI 20000303 A FI20000303 A FI 20000303A FI 20000303 A0 FI20000303 A0 FI 20000303A0
Authority
FI
Finland
Prior art keywords
alpha
prevention
treatment
compounds useful
mediated disease
Prior art date
Application number
FI20000303A
Other languages
Finnish (fi)
Swedish (sv)
Inventor
Siegfried Wurster
Mia Engstroem
Liisa Huovinen
Sari Kalliokoski
Leila Kelanne
Eeva-Liisa Savola
Original Assignee
Juvantia Pharma Ltd Oy
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Juvantia Pharma Ltd Oy filed Critical Juvantia Pharma Ltd Oy
Priority to FI20000303A priority Critical patent/FI20000303A0/en
Publication of FI20000303A0 publication Critical patent/FI20000303A0/en
Priority to PL01357872A priority patent/PL357872A1/en
Priority to JP2001557564A priority patent/JP2003522148A/en
Priority to MXPA02007454A priority patent/MXPA02007454A/en
Priority to EA200200846A priority patent/EA200200846A1/en
Priority to KR1020027010329A priority patent/KR20020080413A/en
Priority to BR0108221-3A priority patent/BR0108221A/en
Priority to SK1147-2002A priority patent/SK11472002A3/en
Priority to CZ20022884A priority patent/CZ20022884A3/en
Priority to CA002399421A priority patent/CA2399421A1/en
Priority to GE4893A priority patent/GEP20043356B/en
Priority to HU0300032A priority patent/HUP0300032A3/en
Priority to PCT/FI2001/000105 priority patent/WO2001058454A1/en
Priority to EP01907585A priority patent/EP1253926A1/en
Priority to EEP200200435A priority patent/EE200200435A/en
Priority to NZ520500A priority patent/NZ520500A/en
Priority to AU35510/01A priority patent/AU780802B2/en
Priority to YU59102A priority patent/YU59102A/en
Priority to IL15101701A priority patent/IL151017A0/en
Priority to MYPI20010579A priority patent/MY133957A/en
Priority to IS6476A priority patent/IS6476A/en
Priority to NO20023773A priority patent/NO20023773L/en
Priority to HRP20020746 priority patent/HRP20020746A2/en

Links

FI20000303A 2000-02-11 2000-02-14 Compounds Useful for the Treatment or Prevention of Alpha-2B Adrenoceptor Mediated Disease FI20000303A0 (en)

Priority Applications (23)

Application Number Priority Date Filing Date Title
FI20000303A FI20000303A0 (en) 2000-02-14 2000-02-14 Compounds Useful for the Treatment or Prevention of Alpha-2B Adrenoceptor Mediated Disease
IL15101701A IL151017A0 (en) 2000-02-11 2001-02-07 Compounds useful for the treatment or prevention of a disease mediated by the alpha-2b-adrenoceptor
GE4893A GEP20043356B (en) 2000-02-11 2001-02-07 Compounds Useful For Treatment or Prevention of Diseases Mediated By Alpha- 2B-Adrenoceptor
PCT/FI2001/000105 WO2001058454A1 (en) 2000-02-11 2001-02-07 Compounds useful for the treatment or prevention of a disease mediated by the alpha-2b-adrenoceptor
MXPA02007454A MXPA02007454A (en) 2000-02-11 2001-02-07 Compounds useful for the treatment or prevention of a disease mediated by the alpha 2b adrenoceptor.
EA200200846A EA200200846A1 (en) 2000-02-11 2001-02-07 CONNECTIONS USEFUL FOR THE TREATMENT OR PREVENTION OF DISEASES MEDIATED BY ALPHA-2B-ADRENOCEPTOR
KR1020027010329A KR20020080413A (en) 2000-02-11 2001-02-07 Compounds useful for the treatment or prevention of a disease mediated by the alpha-2b-adrenoceptor
BR0108221-3A BR0108221A (en) 2000-02-11 2001-02-07 Use of a selective alpha-2b-adrenoceptor antagonist for the manufacture of a pharmaceutical preparation and method for treating or preventing an alpha-2b-adrenoceptor-mediated disease in a mammal
SK1147-2002A SK11472002A3 (en) 2000-02-11 2001-02-07 Compounds useful for the treatment or prevention of a disease mediated by the alpha-2b-adrenoceptor
CZ20022884A CZ20022884A3 (en) 2000-02-11 2001-02-07 Compounds useful for treating or prophylaxis of diseases mediated by alpha-2B- adrenoceptors
CA002399421A CA2399421A1 (en) 2000-02-11 2001-02-07 Compounds useful for the treatment or prevention of a disease mediated by the alpha-2b-adrenoceptor
PL01357872A PL357872A1 (en) 2000-02-11 2001-02-07 Compounds useful for the treatment or prevention of a disease mediated by the alpha-2b-adrenoceptor
HU0300032A HUP0300032A3 (en) 2000-02-11 2001-02-07 Use of compounds useful for the treatment or prevention of a disease mediated by the alpha-2b-adrenoreceptor for preparation of pharmaceutical composition
JP2001557564A JP2003522148A (en) 2000-02-11 2001-02-07 Compounds useful for treating or preventing diseases mediated by alpha-2B-adrenergic receptor
EP01907585A EP1253926A1 (en) 2000-02-11 2001-02-07 Compounds useful for the treatment or prevention of a disease mediated by the alpha-2b-adrenoceptor
EEP200200435A EE200200435A (en) 2000-02-11 2001-02-07 Selective alpha-2B adrenoceptor antagonists and their use
NZ520500A NZ520500A (en) 2000-02-11 2001-02-07 Sulfonamides useful for the treatment or prevention of a disease i.e. vascular and coronary heart disease mediated by the alpha-2B-adrenoceptor
AU35510/01A AU780802B2 (en) 2000-02-11 2001-02-07 Compounds useful for the treatment or prevention of a disease mediated by the alpha-2B-adrenoceptor
YU59102A YU59102A (en) 2000-02-11 2001-02-07 COMPOUNDS USEFUL FOR THE TREATMENT OR PREVENTION OF A DISEASE MEDIATED BY THE ALPHA-2β-ADRENOCEPTOR
MYPI20010579A MY133957A (en) 2000-02-11 2001-02-09 "compounds useful for the treatment or prevention of a disease mediated by the alpha-2b-adrenoceptor"
IS6476A IS6476A (en) 2000-02-11 2002-07-19 Compounds useful for the treatment or prevention of a disease occurring through alpha-2B-adrenoceptor receptors
NO20023773A NO20023773L (en) 2000-02-11 2002-08-09 Compounds useful for treating or preventing a disease mediated by alpha-2B adrenoceptor
HRP20020746 HRP20020746A2 (en) 2000-02-11 2002-09-11 Compounds useful for the treatment or prevention of a disease mediated by the alpha-2b-adrenoceptor

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FI20000303A FI20000303A0 (en) 2000-02-14 2000-02-14 Compounds Useful for the Treatment or Prevention of Alpha-2B Adrenoceptor Mediated Disease

Publications (1)

Publication Number Publication Date
FI20000303A0 true FI20000303A0 (en) 2000-02-14

Family

ID=8557469

Family Applications (1)

Application Number Title Priority Date Filing Date
FI20000303A FI20000303A0 (en) 2000-02-11 2000-02-14 Compounds Useful for the Treatment or Prevention of Alpha-2B Adrenoceptor Mediated Disease

Country Status (1)

Country Link
FI (1) FI20000303A0 (en)

Similar Documents

Publication Publication Date Title
EE200200716A (en) Compounds for the Treatment of Alzheimer's Disease
IL159344A0 (en) Quinuclidines-substituted-multicyclic-heteroaryls for the treatment of disease
IL160884A0 (en) Azabicyclic-substituted fused-heteroaryl compounds for the treatment of disease
FIU20060389U0 (en) Treatment of bone diseases
DE60124302D1 (en) THIAZONE DERIVATIVES FOR THE TREATMENT OF PPAR-LIFE DISEASES
NO20035156L (en) Well Treatment Procedures
DE60219292D1 (en) PYRAZONE DERIVATIVES FOR THE TREATMENT OF HIV
ATE455106T1 (en) ACYL DERIVATIVES FOR THE TREATMENT OF VLA-4 RELATED DISEASES
IL150742A0 (en) Pyridopyrimidinone derivatives for the treatment of neurodegenerative disease
DE50206657D1 (en) PHARMACEUTICAL COMPOSITION FOR THE TREATMENT OF MULTIPLE SCLEROSIS
ATE275145T1 (en) CHINAZOLINE DERIVATIVES FOR THE TREATMENT OF TUMORS
NO20052894D0 (en) 4-tetrazolyl-4-phenylpiperidine derivatives for the treatment of pain
IT1318649B1 (en) PHARMACEUTICAL COMPOSITIONS FOR THE TREATMENT OF MUCOSITES AND STOMATITIS.
NO20034590L (en) Procedures for the treatment of vascular disease
EE200200571A (en) Hydroxyphenylpiperidine-4-ylidenemethylbenzamide derivatives for the treatment of pain
PT1154777E (en) MEDICATION FOR THE TREATMENT OF ARTERIAL HYPERTENSION
DE60223576D1 (en) SKIN TREATMENT COMPOSITION
ATE389742T1 (en) TISSUE TREATMENT PRODUCTS
NO20033804L (en) Carbamate compounds for the treatment of pain
FR2860154B1 (en) COMPOSITION FOR THE TREATMENT OF MALE BREATH
IS5951A (en) 5HT1 antidepressant for the treatment of depression
EE200200511A (en) Hydroxyphenylpiperazinylmethylbenzamide derivatives for the treatment of pain
EE200200577A (en) Quinolinylpiperidin-4-ylidenemethylbenzamide derivatives for the treatment of pain
DE60220220D1 (en) Blood treatment system
ATE374011T1 (en) SKIN TREATMENT PRODUCTS